NEW YORK (360Dx) – Alere has launched a new lateral flow immunoassay for malaria developed with support from the Bill and Melinda Gates Foundation, PATH, and the Foundation for Innovative New Diagnostics, and plans to make the test available in low-resource settings for a price of $1 per test.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.